Kallyope heads to Phase 3 with migraine drug after mid-stage success

FierceBiotechCompass, Usona score FDA national priority vouchers amid Trump administration’s psychedelic push

BioWorldMoney raised by biopharma

BioWorldBiopharma money raised: Jan. 1-April 23, 2026

FierceBiotechChutes & Ladders—Helus shuffles out CEO after two months, adds experience to science board

FierceBiotechAfter Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy?

BioWorldIn the clinic for April 24, 2026

BioWorldOther news to note for April 24, 2026

BioWorldRegulatory actions for April 24, 2026

PLoS BiologyA cortico-subthalamic circuit rapidly engages and releases inhibition of specific movements depending on the environmental context

PLoS BiologyA mother’s gift: Provisioning of plastid-derived structures into eggs promotes invertebrate development and dispersal

PLoS BiologyEmergent spatial structure in the gut microbiota is driven by bacterial growth and gut contractions

BioWorldSichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists